Other languages Champions Oncology, Inc.

Equities

CSBR

US15870P3073

Market Closed - Nasdaq Other stock markets 04:30:00 2024-06-04 pm EDT			5-day change	1st Jan Change
4.615 ^USD	-3.25%		+0.98%	-17.88%

Mar. 15	Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	CI
Mar. 13	Craig-Hallum Downgrades Champions Oncology to Hold From Buy	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Mar. 12
Champions Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Dec. 12
MORNING BID AMERICAS-Disinflation station	Dec. 12
Champions Oncology, Inc: Champions Oncology erhält für seinen europäischen Forschungsstandort eine ISO-9001:2015-Akkreditierung und ATS-Zertifizierung	Nov. 02
Champions Oncology, Inc. Appoints Brady Davis as President	23-10-17
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	23-09-13
Champions Oncology Enters Multiyear Deal With BioVolume to Better Evaluate Cancer Studies	23-08-01
Champions Oncology, Inc. Announces Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies	23-08-01
Champions Oncology, Inc. Reports Earnings Results for the Full Year Ended April 30, 2023	23-07-24
Champions Oncology, Inc. Reports Earnings Results for the Fourth Quarter Ended April 30, 2023	23-07-24
Champions Oncology, Inc. announces an Equity Buyback for $5 million worth of its shares.	23-04-05
Champions Oncology, Inc. authorizes a Buyback Plan.	23-03-28
Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	23-03-15
Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	23-03-15
Champions Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	22-12-13
Champions Oncology, Inc. Provides Revenue Guidance for the Fiscal Year 2023	22-12-13
Champions Oncology Q2 EPS Declines, Revenue Rises to Record Level	22-12-13
Champions Oncology Fiscal Q1 Profit Slips, Revenue Rises	22-09-08
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2022	22-09-08
Champions Oncology, Inc. Reports Earnings Results for the Fourth Quarter Ended April 30, 2022	22-07-21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Champions Oncology, Inc.

Equities

CSBR

US15870P3073

Other languages

Filters